Home / Business / Johnson & Johnson Risperdal verdict: Company struck with $ 8B judgment after drug linked to boy grows breast

Johnson & Johnson Risperdal verdict: Company struck with $ 8B judgment after drug linked to boy grows breast



A Philadelphia jury has ordered Johnson & Johnson to pay $ 8 billion in punitive damages to a man who said he developed breast after taking the company's anti-psychotic drug Risperdal children. The case is not related to a series of big money big things that the company is facing its signature baby powder .

In the Risperdal case, a jury found that Johnson & Johnson failed to warn 26-year-old Nicholas Murray of the drug's side effects. Murray claimed that taking Risperdal as a child caused him to develop breasts, an incurable condition known as gynecomastia. Thousands of others have brought the same case.

Murray said he prescribed the drug at age 9 for symptoms related to autism spectrum disorder, even though the FDA's approval of the drug in the 1

990s was to treat schizophrenia and episodes of bipolar mania in adults.

Lawyers for Murray alleged that the company marketed the drug for unapproved, off-label use in children to increase profits, choosing "billions over children."

Johnson & Johnson denied the allegations and said it is certain that the decision will be reversed. In a statement, the company said it was "excluded from presenting … important evidence …" The company further claimed that evidence showed how the label for the drug "clearly and appropriately accounted for the risks of the drug."

Murray's lawyers told "CBS This Morning" consumer investigation correspondent Anna Werner that the punitive damages were intended to deter the company from similar behavior in the future. They believe the decision will apply.

© 2019 CBS Interactive Inc. All rights reserved.


Source link